Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Anemia and radiotherapy].

David Pasquier1, Eric Lartigau

  • 1Département de radiothérapie, Centre Oscar-Lambret, 59000 Lille.

Bulletin Du Cancer
|July 15, 2003
PubMed
Summary
This summary is machine-generated.

Oxygen enhances radiotherapy's effectiveness, but solid tumors often contain hypoxic areas due to poor vasculature and anemia. Clinical strategies like oxygen breathing, radiosensitizers, and anemia correction aim to overcome this radioresistance.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same authorSame journal

[Reirradiation: A new therapeutic paradigm in oncology].

Bulletin du cancer·2026
Same author

Study Protocol of OLIGOPELVIS 2-GETUG P12: A Randomized Phase 3 Study Comparing Intermittent Androgen-deprivation Therapy with or Without Salvage High-dose Intensity-modulated Radiotherapy to Oligorecurrent Pelvic and Para-aortic Lymph Nodes in Patients with Biochemically Relapsing Prostate Cancer.

European urology oncology·2026
Same author

Magnetic resonance imaging-guided radiotherapy for prostate cancer: A systematic review of the literature.

Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique·2026
Same author

OLIGOPELVIS 2-GETUG P12- elective nodal radiotherapy for oligorecurrent pelvic/para-aortic nodes in prostate cancer: early toxicity of a randomized phase 3 trial.

Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology·2026
Same author

Pushing the Boundaries of Stereotactic Body Radiation Therapy in Irradiated Territories for Nodal Oligorecurrent Prostate Cancer: Outcomes of the CYGNUS Multicentric Retrospective Study.

International journal of radiation oncology, biology, physics·2026
Same author

Salvage stereotactic radiotherapy for locally recurrent brain metastases: a systematic review.

Radiation oncology (London, England)·2026
Same journal

[ONCONNECTE À L'EMPLOI, feedback after three years of a program to prepare for returning to work after cancer in Franche-Comté].

Bulletin du cancer·2026
Same journal

[Off-label use of venetoclax in myeloma].

Bulletin du cancer·2026
Same journal

[Cemiplimab - Adjuvant treatment for the cutaneous squamous cell carcinomas with high risk of relapse, operated and treated by radiotherapy].

Bulletin du cancer·2026
Same journal

Real-world outcomes and management of endometrial cancer in France from 2016 to 2021 (MOONBEAM study).

Bulletin du cancer·2026
Same journal

[Cardiotoxicity in children and adolescents with acute leukemia: Recommendations from the Leukemia Committee of the French Society of Childhood Cancer (SFCE)].

Bulletin du cancer·2026
See all related articles

Area of Science:

  • Oncology
  • Radiation Biology

Context:

  • Radiotherapy effectiveness is significantly influenced by tumor oxygenation.
  • Solid tumors frequently exhibit inadequate vasculature, leading to hypoxic microenvironments.
  • Anemia can exacerbate tumor hypoxia, negatively impacting treatment outcomes.

Purpose:

  • To explore the critical role of oxygen in enhancing the biological effects of ionizing radiation.
  • To review clinical strategies for overcoming tumor hypoxia and anemia in radiotherapy.
  • To discuss methods for measuring tumor oxygenation and the physiological consequences of hypoxia and anemia.

Summary:

  • Oxygen is a potent enhancer of ionizing radiation's biological impact, crucial for effective radiotherapy.
  • Tumor hypoxia, often caused by neo-angiogenesis and anemia, contributes to radioresistance.

Related Experiment Videos

  • Clinical approaches including oxygen breathing, radiosensitizing drugs, and anemia correction are employed to mitigate these challenges.

    • Impact:

    • Understanding tumor oxygenation and its interplay with anemia is vital for optimizing radiotherapy protocols.
    • Improved strategies to address tumor hypoxia can enhance treatment efficacy and patient outcomes.
    • Accurate measurement of tumor oxygenation is essential for personalized radiotherapy planning.